Skip to main content
AVLS Congress and UIP 2023 World Congress Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Stream Session
Live Stream Session
Ticketed Event
Ticketed Event
Invitation Only
Invitation Only
Translation
Translation
Recorded Content
Recorded Content
CME
CME
Non-CME
Non-CME
Back
Watch Recording

International

Connecting the World: Brazil, France, Georgia, Czech Republic, Greece, Costa Rica, Chile

Monday, September 18, 2023
10:30 AM – 12:00 PM US EDT
Location: 235/236/237
Earn 0 CME hour(s)
Evaluate the modern approach to open saphenous vein surgery. advantages, long-term effectiveness and adapting to hybrid procedures

Learning Objectives:

  • Upon completion, participants will be able to analyze the indications.
  • Upon completion, participants will be able to discover the benefits.
  • Upon completion, participants will be able to perform high ligation.
  • Upon complettion participants will understand the management of telangiectasias.

    Program Chair(s)

  • Sergio Gianesini, MD, PhD, FACS

    UIP President-Elect
    University of Ferrara
    USUHS University
    rovigo, Veneto, Italy

    Disclosure(s):

    The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.

  • Jeffery P. Schoonover, MD, RPVI, DABVLM, FAVLS

    Chief Medical Officer, Indiana Vein Specialists
    Indiana Vein Specialists
    Fishers, IN, United States

    Disclosure(s): Tactile: Speaker/Honoraria; VenClose: Speaker/Honoraria

    • Co-Chair(s)

  • Glenn Jacobowitz, MD

    Frank J Veith, MD Professor of Vascular and Endovascular Surgery
    NYU Langone Health
    NYU Grossman School of Medicine
    New York, NY, United States

    Disclosure(s):

    The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.

    • Program Chair(s)

  • Javier A. Serralde Gallegos, Sr. (he/him/his)

    President / Phlebology and Lymphology
    Mexican Academy of Phlebology and Lymphology
    Instituto Politécnico Nacional
    Coyoacán, Distrito Federal, Mexico

    Disclosure(s):

    The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.

  • Pauline Raymond-Martimbeau, MD, CRF, FAVLS, DABVLM (she/her/hers)

    UIP Education Chair
    Dallas non invasive vascular laboratory
    dallas, Texas, United States

    Disclosure(s):

    The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.

    • Co-Chair(s)

  • Alejandro J. Gonzalez Ochoa, MD

    Venous Committee
    Sociedad Mexicana Angiologia y Cirugia Vascular, Society Vascular Surgery,
    San Luis Rio Colorado, Sonora, Mexico

    Disclosure(s): Alfasigma: Consultant/Advisory Board, Research Grant; Servier: Consultant/Advisory Board